Alzheimer's Disease Trial, Recruiting NCT06152211 Sponsor: University of Southern California Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06152211
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with adequate vision and hearing, including those who use glasses or hearing aids for correction
  • People who are fluent in English, as all testing is conducted in English

Who may not be able to join:

  • People with severe hearing loss that cannot be corrected even with hearing aids
  • People with a history of known neurological conditions (affecting the brain or nervous system) or ear/hearing-related conditions (confirm with trial site)
  • People who currently have a severe psychiatric (mental health) disorder — note that past disorders are not automatically disqualifying
  • People with unstable or serious medical conditions that could make it difficult to take part in assessments or attend weekly meetings
  • People whose cognitive (thinking and memory) function is below a certain level, as measured by a standard assessment called the Montreal Cognitive Assessment (MoCA) — specifically, those who score below 26 out of 30
  • People with current or past professional music training, meaning three or more years of regular, formal music practice — though typical school music classes or singing in religious services do not count as professional training

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2137403588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
30 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Speech in Noise Perception ( SIN) as measured by QuickSIN

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov